FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2934586211> ?p ?o ?g. }

• W2934586211 endingPage "2462" @default.
• W2934586211 startingPage "2455" @default.
• W2934586211 abstract "Bivalent (Cervarix®) and quadrivalent (Gardasil®) Human Papillomavirus (HPV) vaccines demonstrate remarkable efficacy against the targeted genotypes, HPV16 and HPV18, but also a degree of cross-protection against non-vaccine incorporated genotypes, HPV31 and HPV45. These outcomes seem to be supported by observations that the HPV vaccines induce high titer neutralizing antibodies against vaccine types and lower responses against non-vaccine types. Few data are available on the robustness of the immune response against non-vaccine types. We examined the durability of vaccine and non-vaccine antibody responses in a follow up of a head-to-head study of 12-15 year old girls initially randomized to receive three doses of Cervarix® or Gardasil® vaccine. Neutralizing antibodies against both vaccine and non-vaccine types remained detectable up to 7 years following initial vaccination and a mixed effects model was used to predict the decline in antibody titers over a 15 year period. The decline in vaccine and non-vaccine type neutralizing antibody titers over the study period was estimated to be 30% every 5-7 years, with Cervarix® antibody titers expected to remain 3-4 fold higher than Gardasil® antibody titers over the long term. The antibody decline rates in those with an initial response to non-vaccine types were similar to that of vaccine types and are predicted to remain detectable for many years. Empirical data on the breadth, magnitude, specificity and durability of the immune response elicited by the HPV vaccines contribute to improving the evidence base supporting this important public health intervention. Original trial: ClinicalTrials.gov NCT00956553." @default.
• W2934586211 created "2019-04-11" @default.
• W2934586211 creator A5001757118 @default.
• W2934586211 creator A5017712981 @default.
• W2934586211 creator A5024940167 @default.
• W2934586211 creator A5032608126 @default.
• W2934586211 creator A5041495695 @default.
• W2934586211 creator A5054039682 @default.
• W2934586211 creator A5062573949 @default.
• W2934586211 creator A5072485453 @default.
• W2934586211 creator A5085306820 @default.
• W2934586211 date "2019-04-01" @default.
• W2934586211 modified "2023-10-12" @default.
• W2934586211 title "Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine" @default.
• W2934586211 cites W1865606554 @default.
• W2934586211 cites W1979230907 @default.
• W2934586211 cites W1981725818 @default.
• W2934586211 cites W1983330985 @default.
• W2934586211 cites W1983636190 @default.
• W2934586211 cites W2006627774 @default.
• W2934586211 cites W2011179095 @default.
• W2934586211 cites W2037903945 @default.
• W2934586211 cites W2045303381 @default.
• W2934586211 cites W2047368772 @default.
• W2934586211 cites W2056922374 @default.
• W2934586211 cites W2083666960 @default.
• W2934586211 cites W2103834380 @default.
• W2934586211 cites W2109016129 @default.
• W2934586211 cites W2127058706 @default.
• W2934586211 cites W2129650487 @default.
• W2934586211 cites W2170701570 @default.
• W2934586211 cites W2264850909 @default.
• W2934586211 cites W2461102849 @default.
• W2934586211 cites W2472221349 @default.
• W2934586211 cites W2512277165 @default.
• W2934586211 cites W2565690359 @default.
• W2934586211 cites W2714435882 @default.
• W2934586211 cites W2763006513 @default.
• W2934586211 cites W2783088490 @default.
• W2934586211 cites W2890878260 @default.
• W2934586211 doi "https://doi.org/10.1016/j.vaccine.2019.03.052" @default.
• W2934586211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30926298" @default.
• W2934586211 hasPublicationYear "2019" @default.
• W2934586211 type Work @default.
• W2934586211 sameAs 2934586211 @default.
• W2934586211 citedByCount "23" @default.
• W2934586211 countsByYear W29345862112019 @default.
• W2934586211 countsByYear W29345862112020 @default.
• W2934586211 countsByYear W29345862112021 @default.
• W2934586211 countsByYear W29345862112022 @default.
• W2934586211 countsByYear W29345862112023 @default.
• W2934586211 crossrefType "journal-article" @default.
• W2934586211 hasAuthorship W2934586211A5001757118 @default.
• W2934586211 hasAuthorship W2934586211A5017712981 @default.
• W2934586211 hasAuthorship W2934586211A5024940167 @default.
• W2934586211 hasAuthorship W2934586211A5032608126 @default.
• W2934586211 hasAuthorship W2934586211A5041495695 @default.
• W2934586211 hasAuthorship W2934586211A5054039682 @default.
• W2934586211 hasAuthorship W2934586211A5062573949 @default.
• W2934586211 hasAuthorship W2934586211A5072485453 @default.
• W2934586211 hasAuthorship W2934586211A5085306820 @default.
• W2934586211 hasBestOaLocation W29345862112 @default.
• W2934586211 hasConcept C121608353 @default.
• W2934586211 hasConcept C126322002 @default.
• W2934586211 hasConcept C159047783 @default.
• W2934586211 hasConcept C159654299 @default.
• W2934586211 hasConcept C203014093 @default.
• W2934586211 hasConcept C22070199 @default.
• W2934586211 hasConcept C22889606 @default.
• W2934586211 hasConcept C2777265743 @default.
• W2934586211 hasConcept C2778220009 @default.
• W2934586211 hasConcept C2779261636 @default.
• W2934586211 hasConcept C2780441014 @default.
• W2934586211 hasConcept C2780801004 @default.
• W2934586211 hasConcept C32611913 @default.
• W2934586211 hasConcept C71924100 @default.
• W2934586211 hasConceptScore W2934586211C121608353 @default.
• W2934586211 hasConceptScore W2934586211C126322002 @default.
• W2934586211 hasConceptScore W2934586211C159047783 @default.
• W2934586211 hasConceptScore W2934586211C159654299 @default.
• W2934586211 hasConceptScore W2934586211C203014093 @default.
• W2934586211 hasConceptScore W2934586211C22070199 @default.
• W2934586211 hasConceptScore W2934586211C22889606 @default.
• W2934586211 hasConceptScore W2934586211C2777265743 @default.
• W2934586211 hasConceptScore W2934586211C2778220009 @default.
• W2934586211 hasConceptScore W2934586211C2779261636 @default.
• W2934586211 hasConceptScore W2934586211C2780441014 @default.
• W2934586211 hasConceptScore W2934586211C2780801004 @default.
• W2934586211 hasConceptScore W2934586211C32611913 @default.
• W2934586211 hasConceptScore W2934586211C71924100 @default.
• W2934586211 hasIssue "18" @default.
• W2934586211 hasLocation W29345862111 @default.
• W2934586211 hasLocation W29345862112 @default.
• W2934586211 hasLocation W29345862113 @default.
• W2934586211 hasOpenAccess W2934586211 @default.
• W2934586211 hasPrimaryLocation W29345862111 @default.
• W2934586211 hasRelatedWork W127545879 @default.
• W2934586211 hasRelatedWork W1972745941 @default.

• next